M&A

J&J Is Exploring a Sale of Its $2 Billion Sterilization Division
Bloomberg
Tue, 02/20/18 - 09:15 am
JNJ
M&A
sterilization
devices
ASP
The Deeply Human Core of Roche's $2.1B Tech Acquisition - And Why They Did It
Forbes
Sun, 02/18/18 - 02:54 pm
Roche
M&A
oncology
R&D
Flatiron Health
EHRs
Novartis May Sell U.S. Generic Pill Business Amid Industry Struggles
TheStreet.com
Sat, 02/17/18 - 10:53 am
Novartis
generics
M&A
AbbVie, Allergan, Roche could join Biogen, UCB in Acorda hunt: analyst
Fierce Pharma
Fri, 02/16/18 - 09:38 pm
AbbVie
Allergan
Roche
Biogen
UCB Pharma
Acorda Therapeutics
M&A
Roche to Acquire Cancer Software Startup Flatiron Health for $1.9B
Xconomy
Thu, 02/15/18 - 11:40 pm
Roche
software
Flatiron Health
M&A
3 Great Acquisition Targets for Gilead Sciences -- and 1 Iffy Candidate
Motley Fool
Thu, 02/15/18 - 11:08 am
Gilead Sciences
M&A
Editas
Madrigal Pharmaceuticals
CRISPR Therapeutics
Galapagos
Stryker nears closure of Vexim takeover, passes 95% ownership
Mass Device
Thu, 02/15/18 - 09:36 am
Stryker
Vexim
M&A
devices
Galapagos tries to avoid being acquired by Gilead
GoinPharma
Mon, 02/12/18 - 04:39 pm
Galapagos
Gilead Sciences
M&A
Amgen still far from performing an important acquisition
GoinPharma
Sun, 02/11/18 - 06:23 pm
Amgen
M&A
How did Sanofi win over Bioverativ? It upped its bid—and called on activist investor Alex Denner
Fierce Pharma
Sat, 02/10/18 - 09:30 am
Sanofi
Bioverativ
M&A
Alex Denner
Allergan snatches Australian aesthetics company Elastagen for $95M
Endpoints
Sat, 02/10/18 - 09:23 am
Allergan
M&A
aesthetics
Elastagen
Sanofi Leads the Hemophilia Space on Bioverativ Acquisition
Market Realist
Wed, 02/7/18 - 10:56 pm
Sanofi
hemophilia
Bioverativ
M&A
With private equity bidders lined up, Sanofi's EU generics could go for up to $2.4B: Reuters
Fierce Pharma
Tue, 02/6/18 - 08:50 pm
M&A
Sanofi
Europe
generics
Nektar Therapeutics reportedly considering a sale
Fierce Biotech
Mon, 02/5/18 - 07:13 pm
Nektar Therapeutics
M&A
Glaxo, Reckitt Submit Only Bids for Pfizer's Consumer Unit
Yahoo/Bloomberg
Sun, 02/4/18 - 11:57 am
GSK
Reckitt Benckiser
M&A
Pfizer
consumer health
Vertex is still one of the top M&A targets
GoinPharma
Sun, 02/4/18 - 11:45 am
Vertex Pharmaceuticals
M&A
Merck KGaA's consumer health sale at risk as Nestle bows out - sources
Yahoo/Reuters
Sat, 02/3/18 - 09:12 am
consumer health
M&A
Merck KGaA
Nestle
Pharma Execs Talk M&A, Drug Pricing Pressures on Earnings Calls
TheStreet.com
Sat, 02/3/18 - 09:07 am
pharma execs
M&A
earnings
drug pricing
Pfizer
Ian Read
Merck
Ken Frazier
Enrique Conterno
Eli Lilly
Amgen’s $70B in ‘deal capacity’ post-tax reform puts the spotlight on ‘big things’ in M&A — analyst
Endpoints
Fri, 02/2/18 - 09:31 am
Amgen
tax reform
M&A
Roche silently scraps two one-time blockbuster hopefuls as $725M Seragon deal craters
Endpoints
Thu, 02/1/18 - 09:49 am
Roche
Seragon
M&A
RG-6047

Pages